Christopher Sjowall
Overview
Explore the profile of Christopher Sjowall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
2274
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parodis I, Wincup C, Touma Z, Andersen J, Strand V, Sjowall C
RMD Open
. 2025 Mar;
11(1).
PMID: 40055003
Despite advancements in the management of systemic lupus erythematosus (SLE), patients experience poor health-related quality of life (hrQoL) and premature death due to disease severity and treatment side effects. Achieving...
2.
Gomez A, Walhelm T, Loeff F, Jonsen A, Nikolopoulos D, van den Broek B, et al.
Rheumatology (Oxford)
. 2025 Mar;
PMID: 40037576
Objective: Studies supporting therapeutic drug monitoring to biopharmaceuticals in systemic lupus erythematosus (SLE) are scarce. We aimed to assess anti-drug antibody (ADA) occurrence in belimumab-treated SLE patients and associations between...
3.
Gomez A, Parodis I, Saleh M, Simard J, Sjowall C, Arkema E
Lupus Sci Med
. 2025 Feb;
12(1).
PMID: 40011068
Objective: To develop a Register-Based Organ Damage Index (RBODI) in SLE, and evaluate its accuracy in estimating Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index (SDI) scores....
4.
Sayadi A, Sandling J, Eloranta M, Jonsen A, Gunnarsson I, Rantapaa-Dahlqvist S, et al.
Lupus Sci Med
. 2025 Feb;
12(1).
PMID: 39933823
Background: SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene variants can cause monogenic SLE. The relationship between common and...
5.
Fugmann C, Reid S, Pucholt P, Kvarnstrom M, Bjork A, Mofors J, et al.
Rheumatology (Oxford)
. 2024 Dec;
PMID: 39693120
Objectives: To calculate a polygenic risk score (PRS) based on single nucleotide variants (SNVs) previously associated with primary Sjögren's disease (SjD) with genome-wide significance, and determine the genetic risk for...
6.
Enocsson H, Lundberg I, Herrmann M, Parodis I, Sjowall C
Front Med (Lausanne)
. 2024 Oct;
11:1491035.
PMID: 39371347
No abstract available.
7.
Parodis I, Sjowall C
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337453
The immense heterogeneity of the chronic, inflammatory, autoimmune disease systemic lupus erythematosus (SLE), both with regard to immunological aberrancies and clinical manifestations, poses diagnostic difficulties and challenges in the management...
8.
Bianchi M, Kozyrev S, Notarnicola A, Sandling J, Pettersson M, Leonard D, et al.
Arthritis Rheumatol
. 2024 Sep;
77(2):212-225.
PMID: 39284741
Objective: Systemic inflammatory autoimmune diseases (SIADs) such as systemic lupus erythematosus (SLE), primary Sjögren disease (pSS), and idiopathic inflammatory myopathies (myositis) are complex conditions characterized by shared circulating autoantibodies and...
9.
Andraos R, Ahmad A, Wirestam L, Dahle C, Frodlund M, Ronnelid J, et al.
Front Med (Lausanne)
. 2024 Sep;
11:1455673.
PMID: 39228805
Background: Anti-nuclear antibodies (ANA) assessed by immunofluorescence (IF) microscopy are associated with systemic autoimmune rheumatic diseases (SARD) and can be detected years before onset of clinical symptoms. Recent data indicate...
10.
Leu Agelii M, Sareila O, Lonnblom E, Cheng L, Forslind K, Hafstrom I, et al.
Rheumatology (Oxford)
. 2024 Jul;
PMID: 39078716
Objective: For better management of rheumatoid arthritis (RA), new biomarkers are needed to predict the development of different disease courses. This study aims to identify autoantibodies against epitopes on proteins...